Pierre Fabre & Avène launch MySun Experience, a simulator to revolutionize the prevention of sun-related skin aging
14 avril 2025
The tool confirms that the correct use of a sun product (SPF30+) could reduce photoaging by up to 50% in some cases.
In 15 years, it will be possible to reduce photoaging for people who follow the prevention advice of the tool:
. by 6 years for a 24-year-old French woman with fair skin,
. by 4 years for a 30-year-old German man with fair skin,
. by 7 years for a 45-year-old Mexican woman with dark skin.
Following the success of the SAFE program conducted in 2024, Pierre Fabre Laboratories and its brand Eau Thermale Avène are launching a new experience for younger generations to raise awareness of the dangers of sun exposure through an innovative simulation.
Imagine a tool that not only applies a filter showing you an older version of yourself but actually predicts the aging of your skin based on your sun protection habits. MySun Experience is this innovation. It is a scientific approach that relies on reliable data and advanced predictive models to offer a personalized experience.
MySun Experience is not an ordinary calculator. It is the result of extensive research and uses behavioral data from the ALL1 study, which involved 50,000 participants from 20 countries. Climate forecasts come from the IPCC2, which includes researchers from 195 countries. Data on the prevalence of skin cancers is provided by GLOBOCAN3, accessible in open data.
Jonathan Serafini, founder of DATA ORA, a pioneering company in artificial intelligence, has developed the predictive model. He explains:
The algorithm is built on identified factors, in scientific publications such as age, sex, phototype, latitude, exposure hours, use of sun protection... It is capable for the first time of predicting sun-related skin aging.
But what is a predictive model? It is the creation of an algorithm that learns from past data and is capable, based on this, of predicting future data!
Pascale Benaksas, president of the FACP association, adds:
This is a major advancement for prevention. Melanoma is one of the most preventable cancers, yet the messages against the dangers of the sun and early skin aging due to unprotected exposure are not resonating enough, particularly with young people who will face increased sunlight exposure rates. This tool helps convey the message.
And this is just the beginning as we are already planning to enrich the model with other factors in partnership with dermatology specialists to predict the aging mechanisms at play in order to respond more individually.
MySun Experience is a tool for awareness and prevention to adopt responsible sun habits.
👉 Starting April 30 click here https://experience.mysun.skin
Together, let's reduce the risks of skin aging and skin cancer.
Simulation Features:
- Personalized Analysis: Based on your characteristics, the tool calculates the risks related to your sun exposure.
- Reliable Predictions: Based on scientific data, predictions are adjusted to your profile.
- Prevention Tips: Receive recommendations to adjust your behaviors and reduce the risks of photoaging and skin cancer.
About SAFE:
As part of its program dedicated to risks related to sun exposure, SAFE (Sun Assessment Family Experience), Pierre Fabre Laboratories launched a consultation with French, Spanish, and German students to imagine new ways to approach melanoma prevention. Indeed, melanoma is one of the most common cancers in Europe among young adults. Its incidence has doubled in France and Germany in 20 years. However, the ALL study conducted in 20 countries with 50,000 participants showed that among 16-34-year-olds, 1 in 2 expose themselves during the hottest hours and 3 in 4 do not reapply sunscreen every 2 hours. When asked why they apply sunscreen: 45% mention preventing skin aging compared to 41% for preventing skin cancers.More information: https://www.mysun.skin/
About Pierre Fabre Laboratories
Pierre Fabre Laboratories is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio includes international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, and Même Cosmetics. Its Medical Care activity covers 4 main therapeutic fields: oncology, dermatology, primary care and family health care.
For over 40 years, Pierre Fabre Laboratories has established itself as an international player in oncology, mastering the entire value chain from R&D to marketing. Its portfolio of oncology specialties covers colorectal, breast, lung and skin cancers, as well as certain hematologic malignancies and precancerous dermatological conditions such as actinic keratosis. In 2024, Pierre Fabre Laboratories’ revenues in oncology came to 520 million euros, over 90% of which were generated by international sales, out of a total sales figure of 3.1 billion euros.
Based in southwest France since its creation, Pierre Fabre Laboratories manufactures more than 90% of its products in France and employs 10,200 people worldwide. In 2024, its R&D budget amounted to 220 million euros, of which 60% is allocated to targeted therapies in oncology and 35% to skin health and care solutions. There are currently 10 research and development programs underway dedicated to targeted therapies in oncology.
Pierre Fabre Laboratories’ majority shareholder (86%) is an eponymous Foundation, which is recognized by the French government as being a public-interest foundation. Employees constitute the company’s other shareholder. This capital structure guarantees the company’s independence, long-term vision and contribution to the common good. The dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.
Pierre Fabre Laboratories’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development).
For more information, visit www.pierre-fabre.com, @Pierre Fabre Oncology
About Data Ora:
Based in Bordeaux, DataOra is a company specializing in data science and data analysis. Founded by Jonathan Serafini, a teacher-researcher, notably in atmospheric physics, affiliated with the University of French Polynesia, DataOra supports its clients in enhancing their data, structuring reliable databases, or developingcustom tools integrating artificial intelligence, such as automatic recognition systems or predictive models. Jonathan places particular importance on projects that have meaning and a positive impact: education, health, culture, environment, by offering solutions designed to be both efficient, understandable, and useful. More information: www.data-ora.com
About FACP
For 14 years, the association France Asso Cancer et Peau has been carrying out 3 missions across France: Prevention - Support - Research. To learn more: https://franceassocanceretpeau.fr/
References:
- ALL Homepage | SAFE - Mysun https://onlinelibrary.wiley.com/share/8FNQBSFSSAJX8KEK6BIV?target=10.1111/jdv.20080
- IPCC (Intergovernmental Panel on Climate Change // GIEC (Groupe d’Experts Intergouvernemental sur l’Evolution du Climat = 15000 researchers worldwide on climate issues) Comprendre le GIEC | Ministères Aménagement du territoire Transition écologique
- GLOBALSCAN https://gco.iarc.fr/en
- European Cancer Information System long term incidence of melanoma 2025- 2040
- International Agency for Research on Cancer Cancer Tomorrow
Media contact:
Laurence MARCHAL
laurence.marchal@pierre-fabre.com
+33 (0)7 88 88 54 47